Dr. Gaerolwe Masheto started working at Botswana Harvard Health Partnership (BHP) Clinical Trial Unit (CTU) in 2011 as a Study Physician and has worked with a team which has successfully conducted International Maternal, Paediatric, Adolescents AIDS Clinical Trials (IMPAACT), AIDS Clinical Trials (ACTG) and HIV Prevention Trials Network (HPTN) clinical trials. He was Gaborone Clinical Research Site (CRS) leader from 2016 to 2022 and Molepolole CRS Leader from 2020 to 2023. He served as the BHP Deputy Chief Executive Officer from March 2023 to August 2025. He also serves as the CTU Coordinator, and the IMPAACT Network Project Leader/Principal Investigator (PI).

Dr. Masheto is also a Co-Investigator for ACTG and HPTN studies. He graduated from Ross University School of Medicine in 2007 with an MD, and from Stellenbosch University in 2012 with Post Graduate Diploma in Family Medicine. He is an alumni for HBNU Global Health Fellowiship and  the International AIDS Society (IAS) Academy-for-Cure Research Fellowship.